Veterinary Endocrinology Market
Report ID: SQMIG35A3367
Report ID: SQMIG35A3367
[email protected]
USA +1 351-333-4748
Report ID:
SQMIG35A3367 |
Region:
Global |
Published Date: March, 2026
Pages:
157
|Tables:
117
|Figures:
77
Global Veterinary Endocrinology Market size was valued at USD 470.0 Million in 2024 and is poised to grow from USD 502.43 Million in 2025 to USD 856.84 Million by 2033, growing at a CAGR of 6.9% during the forecast period (2026-2033).
The global veterinary endocrinology industry represents a complete system which provides diagnostic tests and therapeutic treatments and medical devices and veterinary services to diagnose and treat hormonal disorders in both pet animals and farm animals. The market develops because of pet humanization of animals and improved diagnostic tools, and higher rates of chronic endocrine disease development create demand for this combination of three factors. The market exists because endocrine diseases such as diabetes mellitus, hypothyroidism and hyperthyroidism impact animal welfare, veterinary expenses and pet owner choices.
Moreover, the global veterinary endocrinology market outlook has developed from limited laboratory testing toward point-of-care immunoassays, continuous glucose monitors and targeted hormone therapies, which include expanded insulin product offerings and veterinary clinics that now perform thyroid health tests in-house. The veterinary endocrinology field experiences worldwide growth because clinics now use expanded testing resources to complete their essential work and technological systems now permit efficient disease identification through specific treatment approaches which permit specialized veterinarian services delivery to pet owners. In-clinic continuous glucose monitoring helps diabetic cats by reducing their need for hospitalization because it boosts their treatment progress. The telemedicine follow-up system which connects remote hormone assay results to rural practices permits them to treat hypothyroid dogs without needing to send patients to specialists, this enables testing companies and software developers and specialty biologic manufacturers to expand their business operations through their rural healthcare network.
How is AI Transforming Diagnostics in the Veterinary Endocrinology Market?
AI enhances veterinary endocrinology diagnostics through its ability to improve image analysis, perform automated assay testing and deliver predictive decision-making support to medical specialists. The platforms now use machine learning algorithms for urinalysis and cellular imaging which work with cloud-based systems to deliver standardized results that enable quicker diagnosis times. The market is moving toward in-clinic capability, which helps practices handle increasing patient numbers who experience complex endocrine disorders such as diabetes and thyroid problems. The systems use AI to perform urine sediment analysis while automated cellular analyzers streamline the process of endocrine sample analysis. Zoetis, in June 2025, announced Vetscan Imagyst AI Urine Sediment research at ACVIM which enabled rapid standardized urinalysis at veterinary clinics. The innovation delivers support for endocrinology treatment through its ability to detect diabetes-related urine shifts and maintain monitoring functions while decreasing specialist review needs and enhancing workflow efficiency and speeding up treatment decision-making.
Market snapshot - (2026-2033)
Global Market Size
USD 470.0 Million
Largest Segment
Therapeutic Drugs
Fastest Growth
Diagnostic Kits
Growth Rate
6.9% CAGR
To get more insights on this market click here to Request a Free Sample Report
The global veterinary endocrinology market is segmented based on product category, therapeutic area, animal type, end user, and region. By product category, the market is classified into diagnostic kits, therapeutic drugs, and lab-based instruments. In terms of therapeutic area, it covers thyroid disorders, hyperadrenocorticism, diabetes mellitus management, and Addison’s disease. Based on animal type, the market is divided into companion animals and livestock. By end user, it includes veterinary hospitals, diagnostic and research laboratories, and academic institutes. Geographically, the market is analyzed across North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa.
As per the global veterinary endocrinology market analysis, the lab-based instruments segment maintains its leadership position because advanced analytical platforms deliver comprehensive sensitive endocrine testing and integrate smoothly into veterinary laboratory workflows. The high throughput capabilities of the system together with its automated testing system and wide range of assay options enable laboratories to conduct in-depth analysis of both hormone levels and metabolic pathways which are essential for accurate diagnosis. The diagnostics providers and veterinarians trust the system because it delivers reliable results while enabling laboratory systems to work together, this trust leads to procurement decisions which favor platforms that offer ongoing assay development and clinical validation support.
However, the diagnostic kits segment now shows the fastest growth rate because clinics now test their patients through point-of-care tests which provide immediate test results to help make medical decisions. The veterinary hospitals and smaller practices can perform endocrine testing through the new immunoassays and multiplex rapid formats and simplified sample handling methods. The new technology solutions enable more testing facilities to operate beyond central labs while new product development and service model creation boost market expansion.
According to the global veterinary endocrinology market forecast, the diabetes mellitus management segment demonstrates the highest demand because veterinary practices need customized diabetes treatments and monitoring devices and integrated treatment programs. The need for ongoing insulin therapy, continuous or periodic glucose monitoring and client education creates structured care pathways that encourage investment in specialized drugs, monitoring devices and bundled service offerings. The clinicians who know measurable outcomes will drive advanced management method adoption while commercial organizations will concentrate on complete care solution development.
Whereas the hyperadrenocorticism category is predicted to have the largest veterinary endocrinology market share because better diagnostic tests and increased clinical knowledge have uncovered more treatable patient cases which directly increased demand for both targeted treatments and monitoring systems. The veterinary field has grown through better medical management and new treatment options and increased veterinary training; this progress has created opportunities for drug development and diagnostics enhancement and veterinary specialty service development.
To get detailed segments analysis, Request a Free Sample Report
As per the veterinary endocrinology market regional forecast, the scientific ability of North America combines its clinical needs and its business infrastructure to create an environment which allows for quick development of new technologies. The region advances its translational medical research through dedicated veterinary educational institutions and research centers which support the development of new medical products. The diagnostic requirements for both companion animals and large animals require veterinarians to use specialized endocrine testing and monitoring equipment. The distribution network and laboratory service system provide extensive distribution capabilities while enabling fast access to modern diagnostic tests. The established multinational and local companies continue to maintain their strong presence in clinical networks through their active research and product development work which benefits existing regulatory channels and market conditions. The market remains robust while businesses maintain their top position because professionals understand new technologies and use them in their work.
The Veterinary Endocrinology sector in the United States shows three main characteristics which include high clinical expertise and substantial research activity and strong commercial operations. Advanced diagnostic techniques and monitoring equipment implementation receive support from diagnostic laboratory standards established by major academic institutions and specialized physicians through their development of clinical practice protocols. Veterinary clinics and hospitals which offer laboratory services allow veterinarians to send samples for specialized testing which applies to all types of animals including pets and racehorses and farm animals. The partnership between industrial and academic institutions helps speed up product development and clinical validation processes. The market operates on three essential components which drive demand for new products and high-quality services, and training physicians.
The Veterinary Endocrinology industry in Canada combines advanced clinical operations with collaborative research efforts and comprehensive diagnostic testing services. Veterinary colleges provide ongoing educational programs to practice veterinarians through partnership with provincial veterinary networks which also help distribute new diagnostic technologies. The clinics need to have their animals tested for endocrine diseases because local animal welfare regulations and herd health programs require them to keep their animals healthy. The distribution system along with market connections to regional markets delivers access to a complete range of diagnostic products. The process of validating localized tests combined with practitioner education leads to increased adoption of endocrinology products which serve specialized medical needs.
European countries experience rapid growth because their laws match their improved standards for animal treatment and their active research centers which develop new diagnostic and therapeutic solutions. The demand for precise endocrine tests has increased among pet owners and farmers because they want to monitor their animals' health through preventive medicine. The public-private partnerships and research networks enable organizations to conduct clinical trials while technology transfer occurs through specialized laboratory facilities which exist throughout the entire region. Market consolidation among veterinary service providers and increasing professional specialization create channels for targeted products and educational outreach. The standardized regulations which control cross-border trade make it possible to distribute approved testing equipment while the competitive environment of suppliers drives improvements in diagnostic accuracy and service quality.
The Veterinary Endocrinology Market in Germany depends on two main factors which include its strong manufacturing capabilities and its extensive research facilities dedicated to animal health. The diagnostic manufacturers and specialized laboratories which already exist in the market enable them to perform thorough tests of endocrine assays which deliver results of high accuracy. The veterinary schools and research institutes develop their own medical expertise, which leads to the creation of clinical protocols. The animal health industry maintains its need for specialized tests because it serves both companion animals and equine horses and production animals. The region maintains its market leadership through its focus on exact diagnostic methods and its interconnected laboratory systems.
The Veterinary Endocrinology Market in the United Kingdom experiences sustained growth because private medical practices expand their services through new business partnerships. The clinical innovators network together with specialized centers which provide diagnostic testing services to speed up new testing methods and point-of-care products introduction. The health plans of pet owners increase their demand for complete endocrine assessments. The industry works together with academic centers to validate clinical practices while providing educational training to doctors. The distribution system along with the entrepreneurial services market provides support for market momentum.
The Veterinary Endocrinology Market in France is developing through its increased laboratory capacity and enhanced clinical expertise. Academic laboratories and regional veterinary networks are increasingly engaged in endocrine research and diagnostic validation. The growing interest between practitioners and pet owners about endocrine disorders drives the demand for dependable testing methods. The local providers of manufacturing and services have begun to collaborate with each other to create new testing methods which will shorten the time needed to provide results. The veterinary field improves its diagnostic standards through the combination of clinical education programs and specialized medical services which develop over time.
Asia Pacific improves its capabilities through strategic investments in building capacity and transferring technology and training clinical staff members which help to develop better diagnostic skills. The growth of veterinary infrastructure and laboratory networks and professional specialization development work together to make endocrine testing accessible to more people. The local companies and multinational firms work together to develop regional medical solutions by bringing standardized assays to their local market. The public and private programs for better animal health and productivity create a need for endocrine monitoring in production systems which urbanization and changing companion animal dynamics drive forward. The regional development of the area depends on local manufacturing and regulatory framework development and research partnership creation which will increase the area's importance to international markets.
The Veterinary Endocrinology Market in Japan operates advanced clinical practice facilities that deliver high quality diagnostics through research activities. The establishment of collaborative networks between industry and universities and referral clinics enables the rigorous testing of assays and their application in clinical settings. The evidence-based medicine principles and precision diagnostics methods which clinicians emphasize lead to increased use of specialized endocrine testing in both companion and performance of animal care. The domestic market requires tailored solutions which local manufacturers and laboratory services deliver to create a market profile that supports innovation and established market maturity.
The Veterinary Endocrinology Market in South Korea benefits from a technologically sophisticated biotech sector and proactive clinical adoption of novel diagnostics. The international suppliers and local research centers work together to develop advanced assays and platforms which both organizations have established as their primary testing method. The veterinary sector undergoes rapid modernization and specialty practices to expand, which increases the demand for endocrine testing in both companion animals and production environments. The focus on translational research and commercialization activities establishesan ideal environment to develop breakthrough diagnostic innovations which will enhance clinical outcomes.
To know more about the market opportunities by region and country, click here to
Buy The Complete Report
Growing Companion Animal Population
The rising demand for advanced endocrine diagnostics and therapeutics is driven by the growing number of companion animals and the increased willingness of caregivers to spend on advanced pet healthcare. The growth in pet ownership leads to more pets visiting veterinary clinics which helps to discover and treat endocrine disorders hence driving the need for specialized assays and hormonal therapies and monitoring services. Owners who desire better quality of life push veterinarians to use complete diagnostic procedures together with extended treatment strategies which leads to continuous demand for endocrinology products and services across all clinical and hospital and laboratory and referral locations.
Advances in Diagnostic Technologies
Veterinarians now have improved diagnostic platforms which include sensitive assays and easy-to-use point-of-care tools that help them find and track endocrine disorders more effectively and at an earlier stage. Enhanced diagnostic accuracy helps reduce diagnostic uncertainty, which leads to better treatment results for targeted therapies and supports the long-term tracking of patients who need special reagents and instruments. The industry works on standardizing assays while optimizing workflow processes which promote clinician acceptance and allows medical practices to adopt endocrinology services while increasing their need for related products and laboratory services.
Shortage of Specialized Veterinarians
The global veterinary endocrinology market penetration faces restrictions because of insufficient veterinarians with endocrinology specializations who can diagnose advanced hormonal disorders through specialized testing. The practice without expertise leads to common symptoms being mistaken for different diseases, which results in fewer patients being sent for endocrinology testing and therapies. The restricted access to specialist consultation and training opportunities in specific regions creates an environment where specialist availability limits general practitioner education and new diagnostics adoption and specialized assaying and device demand.
Reimbursement and Cost Constraints
Veterinarians and pet owners will not choose complete testing pathways because of two factors which include the uncertain reimbursement policies and their belief that specialized endocrinology diagnostics and treatments are prohibitively expensive. The clinic will choose cheaper options when coverage is restricted or unpredictable, which will decrease the number of patients needing advanced assays and specialized therapeutics. The concerns about return on investment which facilities have stop them from purchasing dedicated equipment and growing their laboratory services which creates a barrier to disseminating endocrinology-based innovations that slow down their commercial development throughout the country.
Request Free Customization of this report to help us to meet your business objectives.
The global veterinary endocrinology remains competitive because of two main factors which include the demand for point-of-care endocrine testing and continuous glucose monitoring capabilities. The major companies in the industry carry out two strategic activities which involve acquiring other businesses and expanding their laboratory operations, while Zoetis acquired a reference laboratory. The introduction of new products from bioMérieux, which includes its equine insulin and ACTH assays, and the entry of new companies into the pet CGM market, creates competition between companies and their partner channels.
Precision Diagnostics Adoption: Veterinary practices now utilize advanced diagnostic platforms and assays to detect endocrine disorders at earlier stages, which enables them to provide customized treatment plans for their patients. Clinicians choose tests with higher specificity because test results show the most accurate results which enable laboratories and animal health clinics to work together. The combination of service consolidation with technology partnerships creates efficient sample handling processes that enable fast results of delivery because companies use standard protocols to guarantee uniform clinical decision-making. The treatment options available to veterinarians and pet owners have expanded through this trend, which creates a need for dependable endocrinology testing that veterinarians can use across different species.
Biologics and Therapy Innovation: The veterinary endocrinology market is changing through the development of biologic therapies and hormone products which provide veterinarians with treatments that target specific species which have better tolerability for their patients. Pharmaceutical and biotech firms develop long-acting agents and systems to enhance adherence and clinical outcomes, whereasregulatory frameworks expand to allow animal-specific biologics. The combined backing of translational research and industry partnerships accelerates pipeline advancement while clinicians implement evidence-based protocols which include new treatments. The new developments in the industry have created fresh treatment options that are available to both veterinarians and pet owners which enable customized management plans for ongoing disease control.
SkyQuest’s ABIRAW (Advanced Business Intelligence, Research & Analysis Wing) is our Business Information Services team that Collects, Collates, Correlates, and Analyses the Data collected by means ofPrimary Exploratory Research backed by robust Secondary Desk research.
As per SkyQuest analysis, the global veterinary endocrinology market experiences two main growth drivers which include increasing cases of chronic endocrine disorders and the humanization of pets which increases the need for veterinary diagnostic services and persistent medical treatment options. The market faces challenges because there are not enough veterinarians who specialize in endocrinology, which prevents veterinary clinics from using advanced testing methods and clinical procedures. North America maintains its market leadership position because the region has extensive clinical infrastructure and a strong pharmaceutical sector. The laboratory instruments category, which includes laboratory-based instruments, shows its largest share through high throughput systems and comprehensive assay offerings which drive laboratory and referral testing requirements.
| Report Metric | Details |
|---|---|
| Market size value in 2024 | USD 470.0 Million |
| Market size value in 2033 | USD 856.84 Million |
| Growth Rate | 6.9% |
| Base year | 2024 |
| Forecast period | (2026-2033) |
| Forecast Unit (Value) | USD Million |
| Segments covered |
|
| Regions covered | North America (US, Canada), Europe (Germany, France, United Kingdom, Italy, Spain, Rest of Europe), Asia Pacific (China, India, Japan, Rest of Asia-Pacific), Latin America (Brazil, Rest of Latin America), Middle East & Africa (South Africa, GCC Countries, Rest of MEA) |
| Companies covered |
|
| Customization scope | Free report customization with purchase. Customization includes:-
|
To get a free trial access to our platform which is a one stop solution for all your data requirements for quicker decision making. This platform allows you to compare markets, competitors who are prominent in the market, and mega trends that are influencing the dynamics in the market. Also, get access to detailed SkyQuest exclusive matrix.
Table Of Content
Executive Summary
Market overview
Parent Market Analysis
Market overview
Market size
KEY MARKET INSIGHTS
COVID IMPACT
MARKET DYNAMICS & OUTLOOK
Market Size by Region
KEY COMPANY PROFILES
Methodology
For the Veterinary Endocrinology Market, our research methodology involved a mixture of primary and secondary data sources. Key steps involved in the research process are listed below:
1. Information Procurement: This stage involved the procurement of Market data or related information via primary and secondary sources. The various secondary sources used included various company websites, annual reports, trade databases, and paid databases such as Hoover's, Bloomberg Business, Factiva, and Avention. Our team did 45 primary interactions Globally which included several stakeholders such as manufacturers, customers, key opinion leaders, etc. Overall, information procurement was one of the most extensive stages in our research process.
2. Information Analysis: This step involved triangulation of data through bottom-up and top-down approaches to estimate and validate the total size and future estimate of the Veterinary Endocrinology Market.
3. Report Formulation: The final step entailed the placement of data points in appropriate Market spaces in an attempt to deduce viable conclusions.
4. Validation & Publishing: Validation is the most important step in the process. Validation & re-validation via an intricately designed process helped us finalize data points to be used for final calculations. The final Market estimates and forecasts were then aligned and sent to our panel of industry experts for validation of data. Once the validation was done the report was sent to our Quality Assurance team to ensure adherence to style guides, consistency & design.
Analyst Support
Customization Options
With the given market data, our dedicated team of analysts can offer you the following customization options are available for the Veterinary Endocrinology Market:
Product Analysis: Product matrix, which offers a detailed comparison of the product portfolio of companies.
Regional Analysis: Further analysis of the Veterinary Endocrinology Market for additional countries.
Competitive Analysis: Detailed analysis and profiling of additional Market players & comparative analysis of competitive products.
Go to Market Strategy: Find the high-growth channels to invest your marketing efforts and increase your customer base.
Innovation Mapping: Identify racial solutions and innovation, connected to deep ecosystems of innovators, start-ups, academics, and strategic partners.
Category Intelligence: Customized intelligence that is relevant to their supply Markets will enable them to make smarter sourcing decisions and improve their category management.
Public Company Transcript Analysis: To improve the investment performance by generating new alpha and making better-informed decisions.
Social Media Listening: To analyze the conversations and trends happening not just around your brand, but around your industry as a whole, and use those insights to make better Marketing decisions.
REQUEST FOR SAMPLE
REQUEST FREE CUSTOMIZATION
Global Veterinary Endocrinology Market size was valued at USD 470.0 Million in 2024 and is poised to grow from USD 502.43 Million in 2025 to USD 856.84 Million by 2033, growing at a CAGR of 6.9% during the forecast period (2026-2033).
Intense consolidation and diagnostics innovation define the competitive landscape in global veterinary endocrinology, driven by demand for point of care endocrine assays and continuous glucose monitoring. Major players pursue acquisitions and lab rollups exemplified by Zoetis acquiring a reference laboratory, while targeted product launches such as bioMérieux’s equine insulin and ACTH assays and emerging pet CGM entrants sharpen rivalry and channel partnerships. 'Idexx Laboratories', 'Zoetis', 'Bayer Animal Health', 'Merck Animal Health', 'VetMed Labs', 'Vetoquinol', 'Neogen Corporation', 'Ceva Santé Animale', 'Boehringer Ingelheim Animal Health', 'Virbac', 'Elanco', 'Dechra Pharmaceuticals', 'Veterinary Laboratories Agency', 'Triveritas', 'Heska Corporation', 'PetDx', '3M Animal Care', 'Spectrum Labs', 'Animal Health International', 'Animal Metabolomics'
The rising number of companion animals and increased caregiver willingness to invest in advanced healthcare has expanded demand for endocrine diagnostics and therapeutics. Greater pet ownership encourages routine veterinary visits where endocrine disorders are identified and managed, fostering demand for specialized assays, hormonal therapies, and monitoring services. As owners prioritize quality of life, veterinarians adopt more comprehensive diagnostic protocols and long-term treatment plans, creating sustained market uptake of endocrinology products and services across clinics, hospitals, and laboratory settings and referral networks.
Precision Diagnostics Adoption: Veterinary practices increasingly integrate advanced diagnostic platforms and assays to improve endocrine disorder detection, enabling earlier intervention and personalized treatment planning. Clinicians prioritize tests that offer greater specificity and clearer treatment direction, fostering collaboration between laboratories and animal health clinics. Consolidation of services and partnerships with technology providers streamline sample workflows and reporting, while emphasis on standardized protocols supports consistent clinical decisions. These trends elevate diagnostic value perception among owners and practitioners, driving demand for reliable endocrinology testing across species.
Why does North America Dominate the Global Veterinary Endocrinology Market? |@12
Want to customize this report? This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time. We offer $1000 worth of FREE customization at the time of purchase.
Feedback From Our Clients
USA (+1) 351-333-4748
